Novartis shareholders to vote on Alcon deal in April; Genoptix buy on track
This article was originally published in Clinica
Novartis is nearing completion of its bid to buy eyecare company Alcon outright, after setting a date for its shareholders to vote on the final stage of the multi-billion-dollar deal.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.